Glutamatergic agents for schizophrenia: current evidence and perspectives.

Zink, Mathias

Glutamatergic agents for schizophrenia: current evidence and perspectives. [electronic resource] - Expert review of clinical pharmacology May 2015 - 335-52 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1751-2441

10.1586/17512433.2015.1040393 doi


Animals
Antipsychotic Agents--administration & dosage
Cognition Disorders--drug therapy
Dopamine--metabolism
Dose-Response Relationship, Drug
Excitatory Amino Acid Agents--administration & dosage
Glutamic Acid--metabolism
Humans
Patient Selection
Schizophrenia--drug therapy
Schizophrenic Psychology
Treatment Outcome